|
Possible benefit:
|
This randomized study will not likely
benefit the patient who volunteers to participate. It is hoped that
information learned will benefit lung cancer patients in the future |
|
Purpose of trial:
|
The purpose of the randomized trial
is to determine if partial or complete surgical removal of mediastinal
lymph node (located in the chest) is preferred for patients undergoing
surgery for non-small cell lung cancer |
|
Drug/Device being tested:
|
N/A |
|
Sponsoring Department:
|
Surgery |
|
SIU Faculty Physician:
|
Stephen
R. Hazelrigg, M.D., Jacquelyn Quin,
M.D., Theresa Boley, R.N., M.S.N.,
A.P.N./F.N.P. |
|
Sponsoring Company:
|
American College of Surgeons Oncology
Group |
|
Number of other sites in trial:
|
85 |
|
Type of patients needed:
|
Patients with suspected or confirmed
non-small cell lung cancer |
|
Age:
|
18 years and older |
|
Health status:
|
Patients must be medically fit to undergo
surgery for lung cancer including lobectomy (removal of a lung lobe)
or pneumonectomy (removal of the entire lung). They cannot have been
treated for cancer in the last five years |
|
Number of visits required:
|
Patients are seen before and after surgery,
two weeks after surgery, and at 4, 8, 12, 18, 24 and 36 months and
then once a year |
|
Length of study involvement:
|
Patients will be followed for their
lifetime |
|
Tests to be performed:
|
Tests include those routinely used to
prepare for lung cancer surgery -- chest X-ray, CAT scan, serum laboratory
analysis, and possibly a bone or brain scan. Follow-up visits include
a chest X-ray. |
|
Contact Person:
|
Theresa Boley, R.N., M.S.N., A.P.N./F.N.P.,
217-545-5000, E-Mail Address: tboley@siumed.edu |
